Immediate Impact
4 by Nobel laureates 11 from Science/Nature 78 standout
Citing Papers
Natural killer cell therapies
2024 StandoutNature
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
2022 Standout
Works of Carol Ward being referenced
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
2005 Standout
Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Carol Ward | 77 | 1132 | 119 | 509 | 300 | 14 | 1.4k | |
| Rebecca Moroose | 30 | 719 | 68 | 214 | 185 | 22 | 1000 | |
| Domenico Magazzù | 117 | 882 | 52 | 308 | 554 | 18 | 1.3k | |
| Thinh Q. Pham | 105 | 905 | 58 | 406 | 180 | 10 | 1.3k | |
| RD Rubens | 115 | 1312 | 19 | 565 | 256 | 16 | 1.7k | |
| Richard A. Michaelson | 39 | 814 | 58 | 382 | 123 | 18 | 1.0k | |
| David Peston | 153 | 718 | 52 | 192 | 276 | 26 | 1.5k | |
| O.O. Melnyk | 151 | 739 | 119 | 305 | 322 | 26 | 1.6k | |
| Magdalena Koziczak | 41 | 692 | 82 | 378 | 307 | 9 | 1.4k | |
| N. Al-Sakaff | 57 | 868 | 40 | 330 | 311 | 27 | 1.1k | |
| Catherine A. Azar | 161 | 863 | 57 | 143 | 356 | 13 | 1.1k |
All Works
Loading papers...